Evidence map›Paper›PMID 32337043›Full record

ArticleMolecular and clinical oncology2020

Cytopathological evaluation of potential malignancy of duodenal gastrinoma using aspiration smears from two patients' resected tumors (NET G1, NET G2): A case report.

Hirotaka Noda, Kazuyoshi Masuda, Masami Kanbara, Hiromi Maeda, Tadao K Kobayashi, Chikao Yutani

Open access · diamondAbstract read
In one paragraph

Article in Molecular and clinical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hirotaka NodaDepartment of Pathology, Amagasaki Chuo Hospital, Amagasaki, Hyogo 661-0976, Japan.
Kazuyoshi MasudaDepartment of Pathology, Amagasaki Chuo Hospital, Amagasaki, Hyogo 661-0976, Japan.
Masami KanbaraDepartment of Clinical Laboratory, Amagasaki Chuo Hospital, Amagasaki, Hyogo 661-0976, Japan.
Hiromi MaedaDepartment of Clinical Laboratory, Amagasaki Chuo Hospital, Amagasaki, Hyogo 661-0976, Japan.
Tadao K KobayashiDivision of Health Sciences, Cancer Education and Research Center, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Chikao YutaniDepartment of Pathology, Amagasaki Chuo Hospital, Amagasaki, Hyogo 661-0976, Japan.
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporadic gastrin-producing neuroendocrine tumors (NETs) of the duodenum present with either Zollinger-Ellison syndrome or unspecific syndromes. Ki-67 scoring in cytopathology is an alternative approach for establishing the gastrinoma grade. Although the majority of NETs, including gastrinomas, occur in the duodenum, most research regarding the Ki-67 index is focused on tumors of pancreatic origin. To the best of our knowledge, there is no study on the Ki-67 index for cytological analysis of duodenal gastrinoma. The current report presents two cases of a 56-year-old man and a 66-year-old woman with NET G1 and G2 gastrinoma, respectively, arising in the duodenal bulb. The present report focused on the differences in nuclear pleomorphism and Ki-67 index between these two cases.

Indexed as

cytopathologyduodenumgastrinomaimmunocytochemistryKi-67

Identifiers

PMID32337043
PMCPMC7179385
OpenAlexW3015790256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.